Eli Lilly's most recent trend suggests a bullish bias. One trading opportunity on Eli Lilly is a Bull Put Spread using a strike $197.50 short put and a strike $192.50 long put offers a potential 45.35% return on risk over the next 21 calendar days. Maximum profit would be generated if the Bull Put Spread were to expire worthless, which would occur if the stock were above $197.50 by expiration. The full premium credit of $1.56 would be kept by the premium seller. The risk of $3.44 would be incurred if the stock dropped below the $192.50 long put strike price.
The 5-day moving average is moving up which suggests that the short-term momentum for Eli Lilly is bullish and the probability of a rise in share price is higher if the stock starts trending.
The 20-day moving average is moving up which suggests that the medium-term momentum for Eli Lilly is bullish.
The RSI indicator is at 69.17 level which suggests that the stock is neither overbought nor oversold at this time.
To learn how to execute such a strategy while accounting for risk and reward in the context of smart portfolio management, and see how to trade live with a successful professional trader, view more here
LATEST NEWS for Eli Lilly
UPDATE 1-Eli Lilly receives DoJ subpoena over New Jersey manufacturing plant
Thu, 27 May 2021 11:17:35 +0000
Eli Lilly and Co has received a subpoena from the U.S. Department of Justice related to its New Jersey plant that makes its COVID-19 treatment, the drugmaker said in a filing on Thursday. The drugmaker said it was cooperating fully with the investigation. Lilly said it had previously engaged external counsel to conduct an independent investigation of certain allegations relating to the Branchburg plant.
Eli Lilly receives DoJ subpoena over New Jersey manufacturing plant
Thu, 27 May 2021 11:10:31 +0000
The drugmaker said it was cooperating fully with the investigation. Lilly said it had previously engaged external counsel to conduct an independent investigation of certain allegations relating to the Branchburg plant. “Lilly is deeply committed to manufacturing high-quality medicines for patients who need them, and the safety and quality of our products is our highest priority,” the company said.
Regeneron, Novavax CEOs Top List of Highest Paid in 2020
Tue, 25 May 2021 22:37:36 +0000
The 15 highest earners raked in a total of $470 million in compensation
Here's How You Can Earn $10,000 a Year in Retirement
Tue, 25 May 2021 10:33:00 +0000
If you haven't started saving for retirement, it may not be too late to begin. If you have roughly 20 investing years left, then saving $250 each month could be enough to set you up to earn as much as $10,000 per year in recurring dividend income during your retirement years. Let's see how this is possible by investing in a safe healthcare stock like Eli Lilly (NYSE: LLY).
Lilly's (LLY) Tyvyt BLA Accepted for Review by FDA for NSCLC (Revised)
Tue, 25 May 2021 04:41:04 +0000
Lilly (LLY) and Innovent's sintilimab, a PD-1 inhibitor, is marketed by the brand name of Tyvyt in China for two indications.
Also on Market Tamer…
Follow Us on Facebook